| Previous Section | Index | Home Page |
Cancer Research
Vernon Coaker: To ask the Secretary of State for Health how much was spent on research into the causes and treatment of (a) prostate and (b) testicular cancer in (i) 1971, (ii) 1980, (iii) 1990 and (iv) 2000. [4274]
Yvette Cooper: I apologise to my hon. Friend for the delay in responding to this question. I refer my hon. Friend to the reply that my right hon. Friend the Secretary of State gave my hon. Friend the Member for Blackpool, North and Fleetwood (Mrs. Humble) on 5 March 2002, Official Report, column 192W.
11 Mar 2002 : Column 821W
The main Government agency for research into the causes of and treatment for diseases is the Medical Research Council (MRC), which receives its funding via the Department of Trade and Industry. The Department's direct expenditure is on research into policy and the delivery of effective practice in health and social care. The Department's indirect expenditure provides national health service support funding for research commissioned by the research councils and charities that takes place in the NHS.
Figures are not available centrally for expenditure on prostate and testicular cancer research in 1971, 1980 and 1990. The MRC spent £340,000 on prostate cancer research in 2000–01. The Department's direct expenditure was £1,150,000 in 2000–01 but figures for the Department's indirect expenditure on prostate cancer research were not collected centrally in 2000–01. The MRC spent £220,000 on testicular cancer research in 2000–01. The Department had no direct expenditure in 2000–01 on testicular cancer research and figures for indirect expenditure were not collected for 2000–01.
Dialysis (East Lancashire)
Mr. Gordon Prentice: To ask the Secretary of State for Health what estimate he has made of the number of people in East Lancashire who will require dialysis in each year up to 2005. [3841]
Jacqui Smith: I apologise to my hon. Friend for the delay in responding to this question. I refer my hon. Friend to the reply that my right hon. Friend the Secretary of State gave my hon. Friend the Member for Blackpool, North and Fleetwood (Mrs. Humble) on 5 March 2002, Official Report, column 192W.
The estimated number of patients from East Lancashire requiring dialysis in the years up to 2005 are as follows:
| Haemodialysis | Peritoneal dialysis | Total | |
|---|---|---|---|
| 2001 | 117 | 64 | 181 |
| 2002 | 123 | 67 | 190 |
| 2003 | 128 | 70 | 198 |
| 2004 | 135 | 73 | 208 |
| 2005 | 138 | 75 | 213 |
Note:
The calculations were made using the Hennel, Wood and Mallick model and were based on the 1999 stock of renal patients and an annual uptake rate of 92 new patients per million. This is an uptake rate of 80 per million adjusted for the age distribution and ethnicity in the population of East Lancashire.
Pain Clinics
Harry Cohen: To ask the Secretary of State for Health if he will make it his policy for there to be a pain clinic in every major hospital; and if he will make a statement. [5311]
Mr. Hutton: I apologise to my hon. Friend for the delay in responding to this question. I refer my hon. Friend to the reply that my right hon. Friend the Secretary of State gave my hon. Friend the Member for Blackpool, North and Fleetwood (Mrs. Humble) on 5 March 2002, Official Report, column 192W.
Chronic pain services exist in 220 acute hospitals, 88 per cent. of acute hospitals in the United Kingdom.
11 Mar 2002 : Column 822W
The Clinical Standards Advisory Group (CSAG) report on "Services for Patients with Pain" published in April 2000 highlighted variations between hospitals in quality and access to pain management services. Trusts should review the services they provide against the standards set out in the CSAG report and other guidance. In this review account should be taken of the needs of both adults and children, and include patients with acute pain resulting from sudden illness or accident, as well as post-operative pain and chronic pain. Trusts should also agree with commissioners the services and resources which are appropriate to meet local needs.
St. George's Hospital, Tooting
Mr. Cox: To ask the Secretary of State for Health how many people were treated at the accident and emergency department of St. George's hospital, Tooting, in 2000. [4881]
Mr. Hutton: I apologise to my hon. Friend for the delay in responding to this question. I refer my hon. Friend to the reply that my right hon. Friend the Secretary of State gave my hon. Friend the Member for Blackpool, North and Fleetwood (Mrs. Humble) on 5 March 2002, Official Report, column 192W.
In the financial year 1999–2000, St. George's Healthcare National Health Service Trust had a total of 82,718 accident and emergency attendances, 78,898 being first attendances.
Bed Blocking (Buckinghamshire)
Mr. Goodman: To ask the Secretary of State for Health how many operations have been cancelled in Buckingham, in each quarter in 2000 and 2001, as a result of hospital beds being occupied by (a) delayed discharge patients who were awaiting social services funding or assessment or (b) delayed discharge patients who had fully funded social services packages arranged. [5638]
Jacqui Smith: I apologise to the hon. Member for the delay in responding to this question. I refer the hon. Member to the reply that my right hon. Friend the Secretary of State gave my hon. Friend the Member for Blackpool, North and Fleetwood (Mrs. Humble) on 5 March 2002, Official Report, column 192W.
The information is not available in the format requested.
Drug Treatment Programmes
Paul Flynn: To ask the Secretary of State for Health what his estimate is of the level of participation of problem drug users in drug treatment programmes in each year since 1997. [5886]
Ms Blears: I apologise to my hon. Friend for the delay in responding to this question. I refer my hon. Friend to the reply that my right hon. Friend the Secretary of State gave my hon. Friend the Member for Blackpool, North and Fleetwood (Mrs. Humble) on 5 March 2002, Official Report, column 192W.
It is estimated that there were around 118,500 drug misusers in treatment in England in 2000–01 (from "Statistics from the Regional Drug Misuse Databases on drug misusers in treatment in England, 2000–01");
11 Mar 2002 : Column 823W
comparable information is not available for earlier years. The number of users presenting to drug misuse agencies (including both doctors and other agencies) in England in each of the six month periods ending 31 March 1997 to 31 March 2001 is given in the table. Figures exclude treatment in prisons.
| Number | |
|---|---|
| March 1997 | 25,925 |
| September 1997 | 21,996 |
| March 1998 | 23,916 |
| September 1998 | 28,599 |
| March 1999 | 28,499 |
| September 1999 | 30,545 |
| March 2000 | 31,815 |
| September 2000 | 33,093 |
| March 2001 | 33,234 |
Source:
Statistics from the Regional Drug Misuse Databases, Department of Health
Trivax Vaccines
Norman Baker: To ask the Secretary of State for Health which health authorities inoculated children with Wellcome's Trivax vaccines that came from (a) batch 3741 and (b) batch 3732; how many children were so vaccinated; how many adverse reactions were reported in respect of each batch, including fatalities; if he will take steps to trace those who have been inoculated with vaccines from these batches; and if he will make a statement. [5695]
Yvette Cooper [holding answer 20 July 2001]: I apologise to the hon. Member for the delay in responding to this question. I refer the hon. Member to the reply that my right hon. Friend the Secretary of State gave my hon. Friend the Member for Blackpool, North and Fleetwood (Mrs. Humble) on 5 March 2002, Official Report, column 192W.
Batches 3741 and 3732 of Diphtheria, Tetanus and Pertussis (DTP) vaccine are believed to have been manufactured and distributed in Eire in the late 1960s and early 1970s. At that time DTP vaccine was not provided by the Department but was either purchased by local health authorities or obtained by general practitioners (GPs) from local retail pharmacists. Thus, information on whether batches 3741 and 3732 were supplied to United Kingdom doctors is not held centrally. Should such vaccines have been issued, the only information on who might have received them will depend on GPs or local health authority clinics maintaining records that will be now over 30-years-old. The Department has asked the then manufacturer's present owners, GlaxoSmithKline, to investigate their records. The National Institute for Biological Standards and Control has also been asked to investigate whether they tested these vaccines.
Extensive investigation of the safety of pertussis vaccines was undertaken during the 1970s and early 1980s following negative publicity about brain damage following pertussis immunisation. In 1981 a major report was published by the Committee on Safety of Medicines and the Joint Committee on Vaccination and Immunisation which investigated pertussis vaccine, including suspected adverse
11 Mar 2002 : Column 824W
reactions to the vaccine. The report of this investigation was published in 1981 ("Whooping Cough", HMSO, ISBN 0 11 3207646) and advises on page 47 that
- "From 1964 onwards, all vaccines used in the UK also conformed to World Health Organisation standards of preparation and potency".
Investigation of reports of suspected adverse reactions following pertussis containing vaccines (principally DTP vaccine) reveals no rise in reactions during the period when, if they were used in the UK, batches 3741 and 3732 might have been given (late 1960s and early 1970s) (see table).
| Year | Number of reports received |
|---|---|
| 1964 | 92 |
| 1965 | 69 |
| 1966 | 42 |
| 1967 | 63 |
| 1968 | 40 |
| 1969 | 44 |
| 1970 | 36 |
| 1971 | 44 |
| 1972 | 37 |
| 1973 | 19 |
| 1974 | 37 |
| 1975 | 15 |
| 1976 | 46 |
| 1977 | 127 |
| 1978 | 143 |
| 1979 | 168 |
| 1980 | 209 |
Note:
Suspected adverse reaction reports for pertussis containing vaccine collected via the Committee on Safety of Medicine's Yellow Card Scheme
These figures represent suspected adverse reactions associated with single and multi-component pertussis- containing vaccines. It should be noted that a report of a suspected adverse reaction does not necessarily mean that it was caused by the vaccine. Many vaccines are administered in combination and in these circumstances it may be difficult to ascribe the cause of the reaction to an individual vaccine.
Adverse reporting rates are influenced by many factors, including the extent of use of a drug or vaccine and any publicity about the vaccine.
11 Mar 2002 : Column 825W
| Next Section | Index | Home Page |